環球醫療(2666.HK):普通股持有人應占期內溢利同比增加約9%
格隆匯4月27日丨環球醫療(2666.HK)公佈,截至2022年3月31日止3個月,集團經營業績總體實現平穩增長:收入同比增加約15%,期內溢利同比增加約8%,普通股持有人應占期內溢利同比增加約9%。金融業務方面,集團持續穩中求進步調,在全力保障風險控制與資產安全的前提下有序開拓業務。2022年3月31日,集團生息資產總額較2021年底實現持續增長,淨息差與淨利差保持穩定,資產質量保持良好。醫院集團運營方面,集團所管理的成員醫療機構一季度受多地疫情影響,核酸檢測工作大量增加,致使總診療人次同比明顯增長,剔除核酸人次後同比增幅約10%;出院人次受疫情影響,同比增加僅3%;體檢人次同比增幅約25%;合計醫療業務收入同比增幅約8%。醫院集團整體運營效益今年1月受陝西疫情影響最為明顯,2-3月陸續開始逐漸恢復。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.